| 000 | 01607 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250516042433.0 | ||
| 264 | 0 | _c20120619 | |
| 008 | 201206s 0 0 eng d | ||
| 022 | _a1437-7780 | ||
| 024 | 7 |
_a10.1007/s10156-011-0262-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHamada, Yukihiro | |
| 245 | 0 | 0 |
_aClinical efficacy of arbekacin for Gram-negative bacteria. _h[electronic resource] |
| 260 |
_bJournal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy _cDec 2011 |
||
| 300 |
_a876-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCoinfection _xdrug therapy |
| 650 | 0 | 4 |
_aDibekacin _xanalogs & derivatives |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGram-Negative Bacteria _xdrug effects |
| 650 | 0 | 4 |
_aGram-Negative Bacterial Infections _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethicillin-Resistant Staphylococcus aureus _xdrug effects |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aStaphylococcal Infections _xdrug therapy |
| 700 | 1 | _aTamura, Kazuyoshi | |
| 700 | 1 | _aKoyama, Ikumi | |
| 700 | 1 | _aKuroyama, Masakazu | |
| 700 | 1 | _aYago, Kazuo | |
| 700 | 1 | _aSunakawa, Keisuke | |
| 773 | 0 |
_tJournal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy _gvol. 17 _gno. 6 _gp. 876-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10156-011-0262-x _zAvailable from publisher's website |
| 999 |
_c20922381 _d20922381 |
||